Targeted delivery to rheumatoid arthritis due to interaction of platelet membrane proteins (GPVI) with overexpressed CD44 and collagen IV in synovial tissuesImproved NP stability, long circulation profile and provide a benefit of passive targeting. This evidence concerns the gene CD44 and rheumatoid arthritis.